Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 97851-97900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04131647
Promotion of Weight Management
NAActive, not recruiting
175 participants
Started: Mar 1, 2021 · Completed: Jan 7, 2026
1 condition3 sponsors2 locations
NCT05305729
Metabolic FingerPrinting
N/ARecruiting
10,000 participants
Started: Mar 1, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor5 locations
NCT04781920
Follow-up of Anterior Cruciate Ligament Reconstruction
N/ARecruiting
200 participants
Started: Mar 1, 2021 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04433858
An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
PHASE2Active, not recruiting
27 participants
Started: Mar 1, 2021 · Completed: May 1, 2026
1 condition2 sponsors2 locations
NCT04691284
Microbiome in Cancer Patients With High Dose Chemotherapy With Stem Cell Transplantation
NARecruiting
100 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04570085
Effect of CAFfeine on Cognition in Alzheimer's Disease
PHASE3Recruiting
248 participants
Started: Mar 1, 2021 · Completed: Nov 30, 2026
1 condition5 sponsors17 locations
NCT03883139
PRISM Intervention Study
NARecruiting
140 participants
Started: Mar 1, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor3 locations
NCT04284267
Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders
NARecruiting
60 participants
Started: Mar 1, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT04937062
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
EARLY_PHASE1Active, not recruiting
50 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
2 conditions7 sponsors2 locations
NCT04781257
Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries
N/AActive, not recruiting
2,100 participants
Started: Mar 1, 2021 · Completed: Apr 30, 2024
1 condition2 sponsors3 locations
NCT04758000
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse
PHASE2Recruiting
67 participants
Started: Mar 1, 2021 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT04571658
NEPTUNE Match Study
N/AEnrolling by invitation
375 participants
Started: Mar 1, 2021 · Completed: Jun 30, 2029
8 conditions2 sponsors16 locations
NCT04758065
Effectiveness of Radial Pressure Waves Therapy in the Treatment of Non-Specific Neck Pain (rPWT)
NAActive, not recruiting
60 participants
Started: Mar 1, 2021 · Completed: Aug 30, 2025
1 condition1 sponsor2 locations
NCT04648046
CAR-T Cells for HIV Infection
PHASE1/PHASE2Recruiting
18 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2029
1 condition2 sponsors2 locations
NCT05035745
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
PHASE1/PHASE2Recruiting
63 participants
Started: Mar 1, 2021 · Completed: Nov 30, 2027
3 conditions1 sponsor1 location
NCT04681781
SLC13A5 Deficiency Natural History Study - Remote Only
N/AEnrolling by invitation
20 participants
Started: Mar 1, 2021 · Completed: Sep 1, 2025
10 conditions2 sponsors1 location
NCT06280794
Efficacy of Laser Acupuncture for Idiopathic Bell's Palsy
NARecruiting
336 participants
Started: Mar 1, 2021 · Completed: Feb 1, 2026
1 condition1 sponsor1 location
NCT04670562
Longitudinal Follow up of Patients With Pleural Effusion
N/ARecruiting
500 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04452461
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
PHASE2Recruiting
30 participants
Started: Mar 1, 2021 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT04099082
Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
N/ARecruiting
14 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2025
3 conditions1 sponsor1 location
NCT05093374
Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting
PHASE4Recruiting
290 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04885374
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
N/ARecruiting
2,000 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2028
1 condition1 sponsor1 location
NCT05916690
Electrochemotherapy for the Treatment of Vulvar Cancer
NARecruiting
20 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04517266
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
NARecruiting
214 participants
Started: Mar 1, 2021 · Completed: Oct 30, 2030
1 condition1 sponsor1 location
NCT04769076
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
PHASE2Not yet recruiting
40 participants
Started: Mar 1, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor0 locations
NCT04665635
Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery
NARecruiting
120 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT05127148
RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL
N/ARecruiting
100 participants
Started: Mar 1, 2021 · Completed: Dec 1, 2026
1 condition1 sponsor2 locations
NCT04230421
Effects of Smartphone-based Treatment for Bipolar Disorder - the Smart Bipolar
NARecruiting
200 participants
Started: Mar 1, 2021 · Completed: Jul 1, 2026
1 condition3 sponsors1 location
NCT04260477
Novel Triple-dose Tuberculosis Retreatment Regimen
PHASE3Recruiting
370 participants
Started: Mar 1, 2021 · Completed: Sep 30, 2025
4 conditions2 sponsors1 location
NCT04505501
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection
PHASE2Active, not recruiting
14 participants
Started: Mar 1, 2021 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05352659
Increasing Effective Mental Health Care for LGBT Clients
NAEnrolling by invitation
600 participants
Started: Mar 1, 2021 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT05357807
Extending and Banding the Roux-en-Y Gastric Bypass
NAActive, not recruiting
375 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2028
1 condition1 sponsor3 locations
NCT04921033
Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease
PHASE3Recruiting
256 participants
Started: Mar 1, 2021 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT04944693
Relationship Between Anterior Tibial Subluxation and the Prognosis of Anterior Cruciate Ligament Reconstruction.
N/AEnrolling by invitation
200 participants
Started: Mar 1, 2021 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT04952272
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
PHASE1Recruiting
50 participants
Started: Mar 1, 2021 · Completed: Jun 30, 2036
3 conditions2 sponsors1 location
NCT06069232
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
N/ARecruiting
2,000 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2028
1 condition8 sponsors7 locations
NCT04573803
Pharmacological Management of Seizures Post Traumatic Brain Injury
PHASE3Not yet recruiting
1,649 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2028
2 conditions2 sponsors0 locations
NCT04828083
Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty
PHASE4Recruiting
120 participants
Started: Mar 1, 2021 · Completed: Nov 30, 2024
2 conditions1 sponsor1 location
NCT05159661
Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment
N/ARecruiting
1,000 participants
Started: Mar 1, 2021 · Completed: Feb 27, 2026
3 conditions15 sponsors5 locations
NCT04179045
A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
NANot yet recruiting
785 participants
Started: Mar 1, 2021 · Completed: Jul 31, 2026
1 condition2 sponsors5 locations
NCT04649008
Localizing Epileptic Networks Using MRI and iEEG
EARLY_PHASE1Recruiting
290 participants
Started: Mar 1, 2021 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT06761313
Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma
PHASE4Active, not recruiting
40 participants
Started: Mar 1, 2021 · Completed: Feb 26, 2025
2 conditions1 sponsor1 location
NCT04711148
A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis
PHASE2Active, not recruiting
160 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2026
1 condition1 sponsor42 locations
NCT04803110
Soft Tissue Volume Changes After Immediate Implants With Two Different Techniques
NAActive, not recruiting
20 participants
Started: Mar 1, 2021 · Completed: Jan 1, 2026
3 conditions1 sponsor1 location
NCT04230278
Efficacy of a Physical Therapy Intervention Targeting Sitting and Reaching for Young Children With Cerebral Palsy
NAActive, not recruiting
100 participants
Started: Mar 1, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor4 locations
NCT04770883
Psychological and Dietary Treatment in IBS
NANot yet recruiting
200 participants
Started: Mar 1, 2021 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT04215510
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
PHASE3Not yet recruiting
286 participants
Started: Mar 1, 2021 · Completed: Mar 1, 2027
1 condition3 sponsors3 locations
NCT05640544
Gamma Entrainment Improve the Recovery of Awareness
NARecruiting
80 participants
Started: Mar 1, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04653012
Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients
NARecruiting
50 participants
Started: Feb 28, 2021 · Completed: Feb 27, 2031
4 conditions1 sponsor1 location
NCT04753203
Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
PHASE1/PHASE2Active, not recruiting
65 participants
Started: Feb 28, 2021 · Completed: Feb 28, 2025
2 conditions1 sponsor1 location